Deltex wins Nijmegen contract

There was more good news from Deltex Medical last week as Radboud University Nijmegen became the first university teaching hospital in Europe to adopt its CardioQ cardiac function monitor as a standard element of surgery. The shares picked up to 20.75p – which compares with the 24.75p at which I tipped them in April last year. Continue to hold.